Our new “Biomanufacturing Insights” series features the experts driving innovation at Rentschler Biopharma. We’re kicking things off with Dante Lepore and a deep dive into one of the most critical moments in any molecule’s journey: tech transfer, and how our dual-site model makes it seamless, predictable, and built for success.
Dante leads our Downstream Process Development team in Milford, MA, where he oversees purification strategies that move from bench to manufacturing with confidence and clarity. His perspective sheds light on why tech transfer isn’t just a handoff; it’s a disciplined, collaborative practice that can make or break a program.
Discover the challenges, opportunities, and why technology transfer has become a key factor in biomanufacturing.
In this interview, discover how
▫️ technology transfer is carried out at Rentschler Biopharma,
▫️ cross-functional collaboration becomes a success factor
▫️ digital advancements are shaping the field
▫️ biopharmaceutical companies can benefit from our dual-site approach
Find out more in Dante’s full interview: https://lnkd.in/eEhTtuxc
RentschlerBiopharma CDMO ReliabilityYouCanTrust TechTransfer
RENTSCHLER BIOPHARMA Launches Our First Edition of Biomanufacturing Insights, Focused on Tech Transfer
Feb 03, 2026
Our new “Biomanufacturing Insights” series features the experts driving innovation at Rentschler Biopharma. We’re kicking things off with Dante Lepore on tech transfer.
Posted by Rentschler Biopharma Inc